Clinical trial
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
NCT00382395 · SOLX, Inc., Industry · Suspended
Key facts
| NCT number | NCT00382395 |
|---|---|
| Title | SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma |
| Official title | Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments |
| Lead sponsor | SOLX, Inc., Industry |
| Status | Suspended |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Glaucoma, Open Angle |
| Intervention type | Device |
| Interventions | SOLX Gold Shunt GMS-plus, Ahmed FP7 Glaucoma Valve |
| Enrollment | 180 |
| Start date | Nov 1, 2005 |
| Primary completion | Jul 1, 2017 |
| Completion | Jul 1, 2017 |
| First posted | Sep 29, 2006 |
| Last update posted | Sep 18, 2015 |
| Countries | Canada, India, Israel, Poland, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: